TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 1 | -8 | 11 | -8 | -21 | -4 |
| S | %wins | 33 | 33 | 100 | 0 | 100 | 100 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/23/04 17:26 | 12/21/04 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Swartz Eric S | CA | D | S.dm | -122 | 1.13 | 0 | -108 | -5 | 2,198 | M | 38 | -53 | -19 | -19 | -16 | -6 | -11 | -6 | -3 | 0 | -9 | 12 | -9 | -23 | |
12/21/04 18:35 | 11/17/04 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Swartz Eric S | CA | D | S.adm | -171 | 1.29 | 0 | -133 | -7 | 1,799 | M | 51 | -53 | -9 | -16 | -11 | -7 | -5 | -7 | 2 | 1 | -12 | 19 | -4 | -18 | |
11/19/04 19:39 | 11/17/04 | PPHM | Peregrine Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Swartz Eric S | CA | D | S.dm | -172 | 1.29 | 0 | -134 | -7 | 1,798 | M | 129 | -52 | -17 | 6 | -19 | -2 | -12 | -10 | 6 | 1 | -4 | 2 | -10 | -21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |